Cargando…

LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent

Detalles Bibliográficos
Autor principal: Zweytick, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shared Science Publishers OG 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859424/
https://www.ncbi.nlm.nih.gov/pubmed/31798060
http://dx.doi.org/10.15698/cst2019.11.202
_version_ 1783471116596019200
author Zweytick, Dagmar
author_facet Zweytick, Dagmar
author_sort Zweytick, Dagmar
collection PubMed
description
format Online
Article
Text
id pubmed-6859424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shared Science Publishers OG
record_format MEDLINE/PubMed
spelling pubmed-68594242019-12-03 LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent Zweytick, Dagmar Cell Stress News and Thoughts Shared Science Publishers OG 2019-11-03 /pmc/articles/PMC6859424/ /pubmed/31798060 http://dx.doi.org/10.15698/cst2019.11.202 Text en Copyright: © 2019 Zweytick. https://creativecommons.org/licenses/by/4.0/ This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.
spellingShingle News and Thoughts
Zweytick, Dagmar
LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title_full LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title_fullStr LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title_full_unstemmed LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title_short LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
title_sort ltx-315 – a promising novel antitumor peptide and immunotherapeutic agent
topic News and Thoughts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859424/
https://www.ncbi.nlm.nih.gov/pubmed/31798060
http://dx.doi.org/10.15698/cst2019.11.202
work_keys_str_mv AT zweytickdagmar ltx315apromisingnovelantitumorpeptideandimmunotherapeuticagent